USADA announced today that Ariel Gibilaro, of Bryan, TX, an athlete in the sport of archery, has accepted a public warning for her anti-doping rule violation.
Gibilaro, 22, tested positive for the presence of canrenone as a result of an out-of-competition urine sample she provided on May 10, 2017. Canrenone is a Specified Substance in the class of Diuretics and Masking Agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing and the World Archery Federation Anti-Doping Rules, both of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency (WADA) Prohibited List.
After a thorough review of the case, including the examination of medical records provided by the athlete, USADA determined that Gibilaro’s positive test was caused by spironolactone, a prescribed medication that she was using in a therapeutic dose under the care of a physician. USADA has since granted Gibilaro a Therapeutic Use Exemption (TUE) authorizing her continued use of this medication.
In an effort to aid athletes, as well as all support team members such as parents and coaches, in understanding the rules applicable to them, USADA provides comprehensive instruction on its website on the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements as well as performance-enhancing and recreational drugs. In addition, USADA manages a drug reference hotline, Global Drug Reference Online (www.GlobalDRO.com), conducts educational sessions with National Governing Bodies and their athletes, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, periodic newsletters, and protocol and policy reference documentation.
USADA is responsible for the testing and results management process for athletes in the U.S. Olympic and Paralympic Movement, and is equally dedicated to preserving the integrity of sport through research initiatives and educational programs.
For more information or media inquiries, click here.